Arcadia Biosciences’ CEO attempts his third turnaround
Sacramento Business Journal
Arcadia Biosciences Inc. CEO Matt Plavan is choreographing a major pivot for the publicly traded seed company, transitioning from developing fringe products to developing products in growth sectors such as wheat and commercial hemp.
It is a familiar situation for Plavan, as he’s helped lead pivots at local public companies twice before.